If PetMeds Is A Good Buy There Will Be A Better Signal
Shares of PetMeds (NASDAQ:PETS) are rocketing higher in the wake of what we can only call a mixed report. The news wasn’t bad and it wasn’t good and it certainly isn’t enough to have shares up by 9%, not unless you factor in the short interest. The short interest was over 21% at the start of the month which is quite a weight for share prices and part of why they have been trending lower over the past several quarters. It is our guess that there is some short-covering going on right now and that this pop in prices is being used by the bears to full advantage because it is so far behind its comp...